Frankfurt, Germany –  PharmaLex Group, one of the most experienced and most successful specialist providers of Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance worldwide, have completed the merger of Arbour Group, LLC in the US.

Arbour Group is a leading global provider of regulatory compliance solutions for the life sciences industry.  Headquartered in Chicago, Illinois, Arbour Group has offices throughout North America along with service delivery centers in Dubai, UAE and Manila, Philippines. 

The addition of Arbour Group will reinforce the existing quality management and compliance portfolio of PharmaLex with expertise in the field of IT Systems Validation and Compliance. This also supports a key focus of delivering Connected Health solutions to help customers address industry advances in Artificial Intelligence, Cloud Applications and GDPR. In addition to strengthening its foothold in the US, the merger will provide PharmaLex the opportunity to expand its global reach and take advantage of the off-shoring capabilities afforded by the Dubai and Manila operations.

“Arbour Group and PharmaLex have a shared commitment to provide reputable solutions with exceptional results that will not only favor our partnership but will also benefit our customers with noteworthy regulatory expertise,” noted Ahsan Raza, President of Arbour Group. 

“Arbour Group is a well-recognized service provider with an excellent reputation in the regulatory compliance market,” explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Their specialist expertise will enable us to drive business in the US whilst allowing us to expand our quality management and compliance service line worldwide,” he added.